To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Giiant Pharma adds to seed funding, AQC, CQDM invest
Montreal-based Giiant Pharma, developer of a precision delivery technology platform in gastroenterology, has raised an additional C$1.25 million for its seed financing.
